immune disease affecting the joints in approximately 1 % of the world’s population [1, 2]. Patients with RA can an effective therapy for established RA [4, 5]. It is believed to be effective by blocking the costimulation of T cells Jansen et al. Arthritis Research & Therapy (2015) 17:220 DOI 10.1186/s13075-015-0731-1disease, the underlying autoimmune response is fully matured. Likewise, it is conceivable that the action of 9600, 2300 RC, Leiden, the Netherlands Full list of author information is available at the end of the articlein whom anti–tumour necrosis factor (anti-TNF) treat-ment has failed. It is likely that, in this phase of * Correspondence
Background: T-cells are pathogenic in rheumatoid arthritis (RA) and have an important role in persis...
To access publisher's full text version of this article click on the hyperlink belowRheumatoid arthr...
The Author(s) 2015. This article is published with open access at Springerlink.com Background Tacrol...
Rheumatoid arthritis (RA) is a chronic inflammatory dis-ease of still unknown etiology with a preval...
Full list of author information is available at the end of the articleIntroduction Patients with rhe...
Abatacept (CTLA-Ig), a modulator of T-lymphocyte activation, has been approved by the Swiss health r...
Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patient...
ill h1 The pathogenesis of rheumatoid arthritis (RA) is charac-terized by the infiltration of inflam...
To access publisher's full text version of this article click on the hyperlink belowObjective: In rh...
Contains fulltext : 141883.pdf (publisher's version ) (Open Access)Tumor necrosis ...
The therapeutic effect of tumor necrosis factor (TNF)inhibition is certainly well recognized from st...
Rheumatoid Arthritis (RA) is a chronic inflammatory disease of erosive nature that tends to progress...
<em>The article contains analysis of international practice of abatacept use in treatment of refract...
DOI 10.1186/s40064-015-0979-6achieve successful remission. Within the last decade the field of thera...
Journal Article;BACKGROUND Persistence of anti-tumor necrosis factor (TNF) therapy in rheumatoid ar...
Background: T-cells are pathogenic in rheumatoid arthritis (RA) and have an important role in persis...
To access publisher's full text version of this article click on the hyperlink belowRheumatoid arthr...
The Author(s) 2015. This article is published with open access at Springerlink.com Background Tacrol...
Rheumatoid arthritis (RA) is a chronic inflammatory dis-ease of still unknown etiology with a preval...
Full list of author information is available at the end of the articleIntroduction Patients with rhe...
Abatacept (CTLA-Ig), a modulator of T-lymphocyte activation, has been approved by the Swiss health r...
Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patient...
ill h1 The pathogenesis of rheumatoid arthritis (RA) is charac-terized by the infiltration of inflam...
To access publisher's full text version of this article click on the hyperlink belowObjective: In rh...
Contains fulltext : 141883.pdf (publisher's version ) (Open Access)Tumor necrosis ...
The therapeutic effect of tumor necrosis factor (TNF)inhibition is certainly well recognized from st...
Rheumatoid Arthritis (RA) is a chronic inflammatory disease of erosive nature that tends to progress...
<em>The article contains analysis of international practice of abatacept use in treatment of refract...
DOI 10.1186/s40064-015-0979-6achieve successful remission. Within the last decade the field of thera...
Journal Article;BACKGROUND Persistence of anti-tumor necrosis factor (TNF) therapy in rheumatoid ar...
Background: T-cells are pathogenic in rheumatoid arthritis (RA) and have an important role in persis...
To access publisher's full text version of this article click on the hyperlink belowRheumatoid arthr...
The Author(s) 2015. This article is published with open access at Springerlink.com Background Tacrol...